Munich Reinsurance Co Stock Corp in Munich acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 174,538 shares of the healthcare conglomerate's stock, valued at approximately $60,268,000. UnitedHealth Group comprises 1.5% of Munich Reinsurance Co Stock Corp in Munich's holdings, making the stock its 25th largest position.
A number of other large investors also recently bought and sold shares of UNH. LFA Lugano Financial Advisors SA acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $25,000. Sagard Holdings Management Inc. acquired a new position in shares of UnitedHealth Group in the second quarter worth about $29,000. Foster Dykema Cabot & Partners LLC boosted its stake in shares of UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 34 shares in the last quarter. Islay Capital Management LLC acquired a new position in UnitedHealth Group in the 2nd quarter worth about $31,000. Finally, Hurley Capital LLC grew its holdings in UnitedHealth Group by 81.6% in the third quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Price Performance
Shares of UNH stock opened at $286.86 on Friday. The firm's 50-day moving average is $308.28 and its two-hundred day moving average is $325.68. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. The company has a market capitalization of $260.38 billion, a PE ratio of 21.75, a price-to-earnings-growth ratio of 1.33 and a beta of 0.41.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.09 by $0.02. The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business's revenue was up 12.3% compared to the same quarter last year. During the same quarter last year, the firm earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Monday, March 9th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.1%. The ex-dividend date is Monday, March 9th. UnitedHealth Group's payout ratio is 67.02%.
Analyst Ratings Changes
Several research analysts have recently weighed in on UNH shares. Royal Bank Of Canada reduced their target price on UnitedHealth Group from $408.00 to $361.00 and set an "outperform" rating for the company in a research note on Wednesday, January 28th. Leerink Partners cut their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an "outperform" rating for the company in a research note on Wednesday, January 28th. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $425.00 to $389.00 and set an "overweight" rating on the stock in a research note on Monday, February 2nd. Oppenheimer lowered their price target on UnitedHealth Group from $415.00 to $385.00 and set an "outperform" rating on the stock in a research note on Wednesday, January 28th. Finally, Morgan Stanley reduced their price objective on UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating for the company in a research note on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $372.13.
Check Out Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
